Zepp Health (ZEPP) Receivables (2016 - 2026)

Zepp Health (ZEPP) has reported Receivables for 11 consecutive years, with $62.4 billion the latest figure, recorded in Q1 2026.

• In Q1 2026, Receivables rose 12.48% year-over-year to $62.4 billion; the TTM figure through Mar 2026 stood at $62.4 billion (up 12.48% YoY), while the FY2025 annual figure was $73.6 billion, up 127899.79% from the prior year.
• Receivables eased to $62.4 billion in Q1 2026 per ZEPP's latest filing, from $73.6 billion in the prior quarter.
• Across five years, Receivables topped out at $163.7 billion in Q2 2022 and bottomed at $25.4 million in Q4 2022.
• Historically, Receivables has averaged $71.8 billion across 5 years, with a median of $73.6 billion in 2025.
• Annual changes were most pronounced in 2023 — Receivables soared 268615.94% — and 2024, when it slumped 99.9%.
• Zepp Health's Receivables stood at $25.4 million in 2022, then jumped by 268615.94% to $68.4 billion in 2023, then plunged by 99.9% to $65.6 million in 2024, then jumped by 112006.11% to $73.6 billion in 2025, then decreased by 15.18% to $62.4 billion in 2026.
• Business Quant data shows ZEPP's Receivables at $62.4 billion in Q1 2026, $73.6 billion in Q4 2025, and $87.2 billion in Q3 2025.